Neuregulin signaling, cortical circuitry development and schizophrenia

Current Opinion in Genetics and Development

Volumn 21, Issue 3, 2011, Pages 262-270

  Rico, Beatriz ^a   Marín, Oscar ^a  

^a INSTITUTO DE NEUROCIENCIAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 4; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEU DIFFERENTIATION FACTOR;

BRAIN CORTEX; BRAIN DEVELOPMENT; CELLULAR DISTRIBUTION; COGNITION; DENDRITIC SPINE; GABAERGIC SYSTEM; HUMAN; INTERNEURON; NERVE CELL NETWORK; NERVE ENDING; NEUROTRANSMISSION; NONHUMAN; PATHOPHYSIOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; REVIEW; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SYNAPTOGENESIS;

ANIMALS; CEREBRAL CORTEX; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; INTERNEURONS; MICE; NEUREGULINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SCHIZOPHRENIA; SIGNAL TRANSDUCTION;

MUS;

EID: 79957590910     PISSN: 0959437X     EISSN: 18790380     Source Type: Journal    
DOI: 10.1016/j.gde.2010.12.010     Document Type: Review

References (64)

1. Owen M.J., Craddock N., O'Donovan M.C. Schizophrenia: genes at last?. Trends Genet 2005, 21:518-525.
2. Lewis D.A., Lieberman J.A. Catching up on schizophrenia: natural history and neurobiology. Neuron 2000, 28:325-334.
3. Sitskoorn M.M., Aleman A., Ebisch S.J., Appels M.C., Kahn R.S. Cognitive deficits in relatives of patients with schizophrenia: a meta-analysis. Schizophr Res 2004, 71:285-295.
4. Lewis D.A., Hashimoto T., Volk D.W. Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci 2005, 6:312-324.
5. Daskalakis Z.J., Fitzgerald P.B., Christensen B.K. The role of cortical inhibition in the pathophysiology and treatment of schizophrenia. Brain Res Rev 2007, 56:427-442.
6. Uhlhaas P.J., Singer W. Abnormal neural oscillations and synchrony in schizophrenia. Nat Rev Neurosci 2010, 11:100-113.
7. Farzan F., Barr M.S., Levinson A.J., Chen R., Wong W., Fitzgerald P.B., Daskalakis Z.J. Evidence for gamma inhibition deficits in the dorsolateral prefrontal cortex of patients with schizophrenia. Brain 2010, 133:1505-1514.
8. Rapoport J.L., Addington A.M., Frangou S., Psych M.R. The neurodevelopmental model of schizophrenia: update 2005. Mol Psychiatry 2005, 10:434-449.
9. Lewis D.A., Levitt P. Schizophrenia as a disorder of neurodevelopment. Annu Rev Neurosci 2002, 25:409-432.
10. Stefansson H., Sigurdsson E., Steinthorsdottir V., Bjornsdottir S., Sigmundsson T., Ghosh S., Brynjolfsson J., Gunnarsdottir S., Ivarsson O., Chou T.T., et al. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 2002, 71:877-892.
11. Harrison P.J., Law A.J. Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology. Biol Psychiatry 2006, 60:132-140.
12. Walsh T., McClellan J.M., McCarthy S.E., Addington A.M., Pierce S.B., Cooper G.M., Nord A.S., Kusenda M., Malhotra D., Bhandari A., et al. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. Science 2008, 320:539-543.
13. Nicodemus K.K., Luna A., Vakkalanka R., Goldberg T., Egan M., Straub R.E., Weinberger D.R. Further evidence for association between ErbB4 and schizophrenia and influence on cognitive intermediate phenotypes in healthy controls. Mol Psychiatry 2006, 11:1062-1065.
14. Silberberg G., Darvasi A., Pinkas-Kramarski R., Navon R. The involvement of ErbB4 with schizophrenia: association and expression studies. Am J Med Genet B 2006, 141:142-148.
15. Norton N., Moskvina V., Morris D.W., Bray N.J., Zammit S., Williams N.M., Williams H.J., Preece A.C., Dwyer S., Wilkinson J.C., et al. Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia. Am J Med Genet B 2006, 141B:96-101.
16. Falls D.L. Neuregulins: functions, forms, and signaling strategies. Exp Cell Res 2003, 284:14-30.
17. Mei L., Xiong W.C. Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. Nat Rev Neurosci 2008, 9:437-452.
18. Bublil E.M., Yarden Y. The EGF receptor family: spearheading a merger of signaling and therapeutics. Curr Opin Cell Biol 2007, 19:124-134.
19. Birchmeier C. ErbB receptors and the development of the nervous system. Exp Cell Res 2009, 315:611-618.
20. Gerecke K.M., Wyss J.M., Karavanova I., Buonanno A., Carroll S.L. ErbB transmembrane tyrosine kinase receptors are differentially expressed throughout the adult rat central nervous system. J Comp Neurol 2001, 433:86-100.
21. Anton E.S., Ghashghaei H.T., Weber J.L., McCann C., Fischer T.M., Cheung I.D., Gassmann M., Messing A., Klein R., Schwab M.H., et al. Receptor tyrosine kinase ErbB4 modulates neuroblast migration and placement in the adult forebrain. Nat Neurosci 2004, 7:1319-1328.
22. Yau H.J., Wang H.F., Lai C., Liu F.C. Neural development of the neuregulin receptor ErbB4 in the cerebral cortex and the hippocampus: preferential expression by interneurons tangentially migrating from the ganglionic eminences. Cereb Cortex 2003, 13:252-264.
23. Flames N., Long J.E., Garratt A.N., Fischer T.M., Gassmann M., Birchmeier C., Lai C., Rubenstein J.L., Marín O. Short- and long-range attraction of cortical GABAergic interneurons by neuregulin-1. Neuron 2004, 44:251-261.
24. Huang Y.Z., Won S., Ali D.W., Wang Q., Tanowitz M., Du Q.S., Pelkey K.A., Yang D.J., Xiong W.C., Salter M.W., et al. Regulation of neuregulin signaling by PSD-95 interacting with ErbB4 at CNS synapses. Neuron 2000, 26:443-455.
25. Garcia R.A., Vasudevan K., Buonanno A. The neuregulin receptor ErbB-4 interacts with PDZ-containing proteins at neuronal synapses. Proc Natl Acad Sci U S A 2000, 97:3596-3601.
26. Okada M., Corfas G. Neuregulin1 downregulates postsynaptic GABAA receptors at the hippocampal inhibitory synapse. Hippocampus 2004, 14:337-344.
27. Kwon O.B., Longart M., Vullhorst D., Hoffman D.A., Buonanno A. Neuregulin-1 reverses long-term potentiation at CA1 hippocampal synapses. J Neurosci 2005, 25:9378-9383.
28. Woo R.S., Li X.M., Tao Y., Carpenter-Hyland E., Huang Y.Z., Weber J., Neiswender H., Dong X.P., Wu J., Gassmann M., et al. Neuregulin-1 enhances depolarization-induced GABA release. Neuron 2007, 54:599-610.
29. Li B., Woo R.S., Mei L., Malinow R. The neuregulin-1 receptor erbB4 controls glutamatergic synapse maturation and plasticity. Neuron 2007, 54:583-597.
30. Neddens J., Buonanno A. Selective populations of hippocampal interneurons express ErbB4 and their number and distribution is altered in ErbB4 knockout mice. Hippocampus 2010, 20:724-744.
31. Vullhorst D., Neddens J., Karavanova I., Tricoire L., Petralia R.S., McBain C.J., Buonanno A. Selective expression of ErbB4 in interneurons, but not pyramidal cells, of the rodent hippocampus. J Neurosci 2009, 29:12255-12264.
32. Fazzari P., Paternain A.V., Valiente M., Pla R., Lujan R., Lloyd K., Lerma J., Marín O., Rico B. Control of cortical GABA circuitry development by Nrg1 and ErbB4 signalling. Nature 2010, 464:1376-1380.
33. Tan W., Dean M., Law A.J. Molecular cloning and characterization of the human ErbB4 gene: identification of novel splice isoforms in the developing and adult brain. PLoS ONE 2010, 5:e12924.
34. Thompson M., Lauderdale S., Webster M.J., Chong V.Z., McClintock B., Saunders R., Weickert C.S. Widespread expression of ErbB2, ErbB3 and ErbB4 in non-human primate brain. Brain Res 2007, 1139:95-109.
35. Krivosheya D., Tapia L., Levinson J.N., Huang K., Kang Y., Hines R., Ting A.K., Craig A.M., Mei L., Bamji S.X., et al. ErbB4-neuregulin signaling modulates synapse development and dendritic arborization through distinct mechanisms. J Biol Chem 2008, 283:32944-32956.
36. Pierri J.N., Chaudry A.S., Woo T.U., Lewis D.A. Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenic subjects. Am J Psychiatry 1999, 156:1709-1719.
37. Konopaske G.T., Sweet R.A., Wu Q., Sampson A., Lewis D.A. Regional specificity of chandelier neuron axon terminal alterations in schizophrenia. Neuroscience 2006, 138:189-196.
38. Cardin J.A., Carlen M., Meletis K., Knoblich U., Zhang F., Deisseroth K., Tsai L.H., Moore C.I. Driving fast-spiking cells induces gamma rhythm and controls sensory responses. Nature 2009, 459:663-667.
39. Fuchs E.C., Zivkovic A.R., Cunningham M.O., Middleton S., Lebeau F.E., Bannerman D.M., Rozov A., Whittington M.A., Traub R.D., Rawlins J.N., et al. Recruitment of parvalbumin-positive interneurons determines hippocampal function and associated behavior. Neuron 2007, 53:591-604.
40. Barros C.S., Calabrese B., Chamero P., Roberts A.J., Korzus E., Lloyd K., Stowers L., Mayford M., Halpain S., Muller U. Impaired maturation of dendritic spines without disorganization of cortical cell layers in mice lacking NRG1/ErbB signaling in the central nervous system. Proc Natl Acad Sci U S A 2009, 106:4507-4512.
41. Chen Y., Hancock M.L., Role L.W., Talmage D.A. Intramembranous valine linked to schizophrenia is required for neuregulin 1 regulation of the morphological development of cortical neurons. J Neurosci 2010, 30:9199-9208.
42. Wen L., Lu Y.S., Zhu X.H., Li X.M., Woo R.S., Chen Y.J., Yin D.M., Lai C., Terry A.V., Vazdarjanova A., et al. Neuregulin 1 regulates pyramidal neuron activity via ErbB4 in parvalbumin-positive interneurons. Proc Natl Acad Sci U S A 2010, 107:1211-1216.
43. Fisahn A., Neddens J., Yan L., Buonanno A. Neuregulin-1 modulates hippocampal gamma oscillations: implications for schizophrenia. Cereb Cortex 2009, 19:612-618.
44. Golub M.S., Germann S.L., Lloyd K.C. Behavioral characteristics of a nervous system-specific erbB4 knock-out mouse. Behav Brain Res 2004, 153:159-170.
45. Chen Y.J., Johnson M.A., Lieberman M.D., Goodchild R.E., Schobel S., Lewandowski N., Rosoklija G., Liu R.C., Gingrich J.A., Small S., et al. Type III neuregulin-1 is required for normal sensorimotor gating, memory-related behaviors, and corticostriatal circuit components. J Neurosci 2008, 28:6872-6883.
46. Karl T., Duffy L., Scimone A., Harvey R.P., Schofield P.R. Altered motor activity, exploration and anxiety in heterozygous neuregulin 1 mutant mice: implications for understanding schizophrenia. Genes Brain Behav 2007, 6:677-687.
47. Gunduz-Bruce H. The acute effects of NMDA antagonism: from the rodent to the human brain. Brain Res Rev 2009, 60:279-286.
48. Belforte J.E., Zsiros V., Sklar E.R., Jiang Z., Yu G., Li Y., Quinlan E.M., Nakazawa K. Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes. Nat Neurosci 2010, 13:76-83.
49. Grunze H.C., Rainnie D.G., Hasselmo M.E., Barkai E., Hearn E.F., McCarley R.W., Greene R.W. NMDA-dependent modulation of CA1 local circuit inhibition. J Neurosci 1996, 16:2034-2043.
50. Li Q., Clark S., Lewis D.V., Wilson W.A. NMDA receptor antagonists disinhibit rat posterior cingulate and retrosplenial cortices: a potential mechanism of neurotoxicity. J Neurosci 2002, 22:3070-3080.
51. Korotkova T., Fuchs E.C., Ponomarenko A., von Engelhardt J., Monyer H. NMDA receptor ablation on parvalbumin-positive interneurons impairs hippocampal synchrony, spatial representations, and working memory. Neuron 2010, 68:557-569.
52. Wang H.X., Gao W.J. Cell type-specific development of NMDA receptors in the interneurons of rat prefrontal cortex. Neuropsychopharmacology 2009, 34:2028-2040.
53. Hahn C.G., Wang H.Y., Cho D.S., Talbot K., Gur R.E., Berrettini W.H., Bakshi K., Kamins J., Borgmann-Winter K.E., Siegel S.J., et al. Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. Nat Med 2006, 12:824-828.
54. Chong V.Z., Thompson M., Beltaifa S., Webster M.J., Law A.J., Weickert C.S. Elevated neuregulin-1 and ErbB4 protein in the prefrontal cortex of schizophrenic patients. Schizophr Res 2008, 100:270-280.
55. Wang X.D., Su Y.A., Guo C.M., Yang Y., Si T.M. Chronic antipsychotic drug administration alters the expression of neuregulin 1beta, ErbB2, ErbB3, and ErbB4 in the rat prefrontal cortex and hippocampus. Int J Neuropsychopharmacol 2008, 11:553-561.
56. Ozaki M., Sasner M., Yano R., Lu H.S., Buonanno A. Neuregulin-beta induces expression of an NMDA-receptor subunit. Nature 1997, 390:691-694.
57. Rieff H.I., Raetzman L.T., Sapp D.W., Yeh H.H., Siegel R.E., Corfas G. Neuregulin induces GABA(A) receptor subunit expression and neurite outgrowth in cerebellar granule cells. J Neurosci 1999, 19:10757-10766.
58. Gajendran N., Kapfhammer J.P., Lain E., Canepari M., Vogt K., Wisden W., Brenner H.R. Neuregulin signaling is dispensable for NMDA- and GABA(A)-receptor expression in the cerebellum in vivo. J Neurosci 2009, 29:2404-2413.
59. Bjarnadottir M., Misner D.L., Haverfield-Gross S., Bruun S., Helgason V.G., Stefansson H., Sigmundsson A., Firth D.R., Nielsen B., Stefansdottir R., et al. Neuregulin1 (NRG1) signaling through Fyn modulates NMDA receptor phosphorylation: differential synaptic function in NRG1+/- knock-outs compared with wild-type mice. J Neurosci 2007, 27:4519-4529.
60. Wang Y.C., Chen J.Y., Chen M.L., Chen C.H., Lai I.C., Chen T.T., Hong C.J., Tsai S.J., Liou Y.J. Neuregulin 3 genetic variations and susceptibility to schizophrenia in a Chinese population. Biol Psychiatry 2008, 64:1093-1096.
61. Chen P.L., Avramopoulos D., Lasseter V.K., McGrath J.A., Fallin M.D., Liang K.Y., Nestadt G., Feng N., Steel G., Cutting A.S., et al. Fine mapping on chromosome 10q22-q23 implicates Neuregulin 3 in schizophrenia. Am J Hum Genet 2009, 84:21-34.
62. Kao W.T., Wang Y., Kleinman J.E., Lipska B.K., Hyde T.M., Weinberger D.R., Law A.J. Common genetic variation in Neuregulin 3 (NRG3) influences risk for schizophrenia and impacts NRG3 expression in human brain. Proc Natl Acad Sci U S A 2010, 107:15619-15624.
63. Morar B., Dragovic M., Waters F.A., Chandler D., Kalaydjieva L., Jablensky A. Neuregulin 3 (NRG3) as a susceptibility gene in a schizophrenia subtype with florid delusions and relatively spared cognition. Mol Psychiatry 2010, [Epub ahead of print].
64. Ting A., Chen Y., Wen L., Ying D., Sheng Ch, Tao Y., Liu X., Xiong W., Mei L. Neuregulin 1 promotes excitatory synapse development and function in GABAergic interneurons. J Neurosci 2011, 31(1):15-25.